Bruker appoints new board director

Skip to Navigation


  • Published: Aug 11, 2015
  • Author: Jon Evans
  • Source: Bruker Corporation
  • Suppliers: Bruker Corporation
  • Channels: Gas Chromatography / Laboratory Informatics / Ion Chromatography / Proteomics & Genomics / Sample Preparation / Electrophoresis / Detectors / HPLC / NMR Knowledge Base / Chemometrics & Informatics / UV/Vis Spectroscopy / Base Peak / Raman / Infrared Spectroscopy / Atomic / X-ray Spectrometry / Proteomics / MRI Spectroscopy
thumbnail image: Bruker appoints new board director

Bruker Corporation has appointed Hermann Requardt to its Board of Directors effective immediately. Requardt will serve for an initial term that expires at the Company’s 2017 Annual Meeting of Stockholders.

Requardt currently serves as an independent strategic advisor to a number of European public and private life science and healthcare technology companies. From 2009 to February 2015, he served as Chief Executive Officer of the healthcare division of Siemens AG.

He has also served as Chief Technology Officer of Siemens AG from 2008 through 2011. Additionally, from 2006 through January 2015, he was a member of the Siemens AG Managing Board, during which time he also held a variety of regional and operational responsibilities at Siemens and its affiliates. Requardt joined Siemens Medical Solutions in 1984, assuming global responsibility for its magnetic resonance business unit in 1994.

Requardt is an honorary professor of physics at the University of Frankfurt. He also serves on several academic and industrial boards in Germany, including, among other positions, vice chairman of Fraunhofer Gesellschaft, Europe’s largest application-oriented research organization, and a member of the Executive Board of Acatech, the German National Academy of Science and Engineering. He also is a member of the Advisory Board of Dekra SE and the Supervisory Board of Sivantos Group, which was Siemens Audiology Solutions prior to its spin-off in early 2015. Requardt holds a PhD in biophysics, with a focus on radiation biophysics and microbiology, from the University of Frankfurt.

‘My relationship with Bruker goes back for decades,’ said Requardt. ‘As a scientist, I loved their products, and as a manager, I enjoyed their collaboration culture and their business ethics. I am proud and happy to finally become a member of the team.’

‘We are truly delighted to have Dr. Requardt join our Board of Directors,’ said Frank Laukien, president & CEO of Bruker. ‘Hermann’s stellar business and executive track record, in combination with his broad experience in healthcare, and in-depth insights into preclinical imaging, molecular diagnostics and microbiology will allow him to make immediate, positive contributions to Bruker.’

(Photo of Hermann Requardt courtesy of Bruker.)

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in spectroscopy? Visit our sister site

Copyright © 2018 John Wiley & Sons, Inc. All Rights Reserved